One of the most popular events of the week, Rheumatology Roundup: Highlights From the 2017 ACR/ARHP Annual Meeting, will help wrap up this year’s meeting. The hour-long session will take […] READ MORE
On Saturday, the ACR Board of Directors met to discuss current and future initiatives impacting its 9,500 members. Here is a summary of the meeting: Increasing Access to High-Quality Education: […] READ MORE
The 2017 Year in Review on Sunday provided a quick overview of the best of basic science and clinical research papers from the past year. Basic science presenter Richard M. […] READ MORE
A universal influenza vaccine? The next big pandemic? What can we expect from the current presidential administration in dealing with emerging or re-emerging infectious disease? Opening Lecture speaker Anthony S. […] READ MORE
A Tuesday morning session will review the preliminary results of the 2016-2017 ACR Update on Rheumatoid Arthritis Disease Activity Measures and 2016-2017 ACR Rheumatoid Arthritis Functional Status Measures. Presenters will […] READ MORE
Many members of the medical community say it is possible to have too much of a good thing. Across all specialties, clinicians and researchers alike suffer from what some call […] READ MORE
Discontinuing methotrexate (MTX) for two weeks after vaccination improves the immunogenicity of a seasonal influenza vaccine in patients with rheumatoid arthritis (RA) on a stable dose of MTX without meaningfully […] READ MORE
A Tuesday ACR/ARHP combined session, Phenotyping Hip & Knee OA: Toward Better Clinical Care & Patient Outcomes, will explore emerging science on osteoarthritis phenotypes and how further understanding of the […] READ MORE
The ACR is about to release its first-ever guideline for the management of psoriatic arthritis (PsA). Written in conjunction with the National Psoriasis Foundation (NPF), the guideline is designed for […] READ MORE
The ACR is collaborating with the European League Against Rheumatism (EULAR) to develop new classification criteria for systemic lupus erythematosus (SLE). SLE is challenging to diagnose and treat, with an […] READ MORE